F-Prime Capital
www.fprimecapital.comVCMatch tracks F-Prime Capital as an investor focused on Biotech, Medtech, and Healthtech companies, Pre-Seed and Seed rounds, and United States, United Kingdom (London), and Cambridge markets. Upload your deck to compare your startup against the full private matching profile.
Check Size
Not specified
Focus Areas
Geography
United States, United Kingdom (London), and Cambridge
Investment Thesis
F-Prime positions itself as a sector-focused, founder-aligned investor that pairs deep domain expertise with active company building. They aim to “turn their boldest ambitions into world-changing breakthroughs” across healthcare and technology, applying a hands-on, operator-informed approach (scientists, engineers, physicians, operators, and investors) to accelerate scalable growth. While they are “early-stage investors by choice,” they are willing to “back exceptional teams at any stage,” and will even create companies when they believe an important problem is unsolved.
Is F-Prime Capital right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
F-Prime Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Medtech, Healthtech, and Enterprise SaaS, especially across United States, United Kingdom (London), and Cambridge.
Focus statement
F-Prime focuses on life sciences (therapeutics, medtech) and healthtech + services in a stage-agnostic fashion, and technology (enterprise software, fintech, frontier tech, and crypto), backing primarily early-stage, category-defining companies but supporting exceptional teams at any stage.
Value Add
- Multidisciplinary, operator-heavy team: “scientists, engineers, physicians, operators, and investors bring real-world expertise” to portfolio companies.
- Company builder mindset: “If we can’t find a company solving an important problem, we create one ourselves,” with examples like Innovent, Denali, Beam, and Ultragenyx.
- Long track record and scale: over 50 years of investing and ~$4.8 billion under management.
- Sector breadth across both healthcare and technology, including an explicit bridge into crypto/web3 (“bridge traditional finance and technology with crypto and web3”).
- Stage flexibility: early-stage by choice but will back exceptional teams at later stages; healthcare described as “stage-agnostic.”
Stage And Sector Fit
Investment Team
3 Partners at F-Prime Capital
See who leads investments in your sector and how to connect with them.
Get partner details
Upload your deck to see who's the best fit for your startup.
Ready to find your perfect investor match?
Get Started Free